315 related articles for article (PubMed ID: 33397952)
1. Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH.
Dong J; Viswanathan S; Adami E; Singh BK; Chothani SP; Ng B; Lim WW; Zhou J; Tripathi M; Ko NSJ; Shekeran SG; Tan J; Lim SY; Wang M; Lio PM; Yen PM; Schafer S; Cook SA; Widjaja AA
Nat Commun; 2021 Jan; 12(1):66. PubMed ID: 33397952
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis.
Pulli B; Ali M; Iwamoto Y; Zeller MW; Schob S; Linnoila JJ; Chen JW
Antioxid Redox Signal; 2015 Dec; 23(16):1255-69. PubMed ID: 26058518
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast-specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease.
Ng B; Dong J; Viswanathan S; Widjaja AA; Paleja BS; Adami E; Ko NSJ; Wang M; Lim S; Tan J; Chothani SP; Albani S; Schafer S; Cook SA
FASEB J; 2020 Sep; 34(9):11802-11815. PubMed ID: 32656894
[TBL] [Abstract][Full Text] [Related]
5. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
6. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
7. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC
J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435
[TBL] [Abstract][Full Text] [Related]
10. Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signaling.
Jiang X; Zhang F; Ji X; Dong F; Yu H; Xue M; Qiu Y; Yang F; Hu X; Bao Z
Cytokine; 2021 Jun; 142():155474. PubMed ID: 33647584
[TBL] [Abstract][Full Text] [Related]
11. Similarities and differences between IL11 and IL11RA1 knockout mice for lung fibro-inflammation, fertility and craniosynostosis.
Ng B; Widjaja AA; Viswanathan S; Dong J; Chothani SP; Lim S; Shekeran SG; Tan J; McGregor NE; Walker EC; Sims NA; Schafer S; Cook SA
Sci Rep; 2021 Jul; 11(1):14088. PubMed ID: 34239012
[TBL] [Abstract][Full Text] [Related]
12. The pro-regenerative effects of hyperIL6 in drug-induced liver injury are unexpectedly due to competitive inhibition of IL11 signaling.
Dong J; Viswanathan S; Adami E; Schafer S; Kuthubudeen FF; Widjaja AA; Cook SA
Elife; 2021 Aug; 10():. PubMed ID: 34435951
[TBL] [Abstract][Full Text] [Related]
13. Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injury.
Widjaja AA; Dong J; Adami E; Viswanathan S; Ng B; Pakkiri LS; Chothani SP; Singh BK; Lim WW; Zhou J; Shekeran SG; Tan J; Lim SY; Goh J; Wang M; Holgate R; Hearn A; Felkin LE; Yen PM; Dear JW; Drum CL; Schafer S; Cook SA
Sci Transl Med; 2021 Jun; 13(597):. PubMed ID: 34108253
[TBL] [Abstract][Full Text] [Related]
14. Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy.
Widjaja AA; Chothani SP; Cook SA
Hum Vaccin Immunother; 2020 Oct; 16(10):2357-2362. PubMed ID: 32530750
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte Specific gp130 Signalling Underlies APAP Induced Liver Injury.
Dong J; Lim WW; Shekeran SG; Tan J; Lim SY; Goh JWT; George BL; Schafer S; Cook SA; Widjaja AA
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806094
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells.
Zhang C; Teng Y; Li F; Ho W; Bai X; Xu X; Zhang XQ
ACS Nano; 2023 Aug; 17(15):14852-14870. PubMed ID: 37490628
[TBL] [Abstract][Full Text] [Related]
17. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.
Du M; Wang X; Yuan L; Liu B; Mao X; Huang D; Yang L; Huang K; Zhang F; Wang Y; Luo X; Wang C; Peng J; Liang M; Huang D; Huang K
J Hepatol; 2020 Dec; 73(6):1333-1346. PubMed ID: 32717288
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function.
Wolff G; Sakurai M; Mhamane A; Troullinaki M; Maida A; Deligiannis IK; Yin K; Weber P; Morgenstern J; Wieder A; Kwon Y; Sekar R; Zeigerer A; Roden M; Blüher M; Volk N; Poth T; Hackert T; Wiedmann L; De Angelis Rigotti F; Rodriguez-Vita J; Fischer A; Mukthavaram R; Limphong P; Tachikawa K; Karmali P; Payne J; Chivukula P; Ekim-Üstünel B; Martinez-Jimenez CP; Szendrödi J; Nawroth P; Herzig S
Mol Metab; 2022 Jun; 60():101487. PubMed ID: 35378329
[TBL] [Abstract][Full Text] [Related]
19. Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.
Davidson MD; Kukla DA; Khetani SR
Integr Biol (Camb); 2017 Aug; 9(8):662-677. PubMed ID: 28702667
[TBL] [Abstract][Full Text] [Related]
20. The marine compound and elongation factor 1A1 inhibitor, didemnin B, provides benefit in western diet-induced non-alcoholic fatty liver disease.
Wilson RB; Chen YJ; Sutherland BG; Sawyez CG; Zhang R; Woolnough T; Hetherington AM; Peters KM; Patel K; Kennelly JP; Leonard KA; Schuurman M; Jacobs RL; Wang R; Borradaile NM
Pharmacol Res; 2020 Nov; 161():105208. PubMed ID: 32977024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
